Gene Transfer into Hepatocytes and Human Liver Tissue by Baculovirus Vectors
- 20 October 1996
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 7 (16) , 1937-1945
- https://doi.org/10.1089/hum.1996.7.16-1937
Abstract
Gene therapy of liver diseases requires the development of efficient vectors for gene transfer in vivo. Retroviral and adenoviral vectors have been shown to deliver genes efficiently into hepatocytes in vitro and in vivo. However, these vectors do not allow for exclusive infection of the liver which would be highly advantageous for in vivo gene therapy strategies. We have recently demonstrated that genetically modified baculoviruses (Autographa californica nuclear polyhedrosis virus) efficiently deliver genes into cultured cells and have a strong preference for hepatocytes of different origin. Baculoviral gene transduction efficiency into human hepatocytes was determined to approach 100% and expression levels are high, provided that gene expression is controlled by mammalian promoters. In this report, we present further properties of baculoviruses regarding their use for hepatocyte gene transfer. Baculovirus-mediated gene expression declines rapidly in the hepatocellular carcinoma cell line Huh7 and more slowly in primary cultures of mouse hepatocytes. Direct application of baculoviruses for gene delivery to the liver in vivo is hampered by serum components, presumably by complement. However, we demonstrate here that baculoviral gene transfer is feasible in ex vivo perfused human liver tissue. This result suggests the development of a strategy using baculoviral vectors for liver-directed gene therapy. This study evaluates baculoviruses for their use in liver gene therapy. We demonstrate that baculovirus-mediated gene delivery is efficient and specific for human hepatocytes in vitro. The kinetics of gene expression mediated by baculovirus vectors are presented for dividing hepatocyte cell lines and nondividing primary cultures of hepatocytes. We describe potential limitations for the application of baculovirus vectors in vivo mainly caused by complement. Strategies of ex vivo perfusion of human liver tissue are feasible.Keywords
This publication has 46 references indexed in Scilit:
- Characterization of an Adenovirus Gene Transfer Vector Containing an E4 DeletionHuman Gene Therapy, 1995
- Ex vivo hepatic gene transfer in mouse using a defective herpes simplex virus-1 vectorHepatology, 1995
- Malarial Circumsporozoite Protein Is a Novel Gene Delivery Vehicle to Primary Hepatocyte Cultures and Cultured CellsJournal of Biological Chemistry, 1995
- Hepatocyte-Specific Binding of L/S-HBV Particles Expressed in Insect CellsBiological Chemistry Hoppe-Seyler, 1995
- Factors Influencing Retroviral-Mediated Gene Transfer into HepatocytesIn VivoHuman Gene Therapy, 1994
- Identification of seven putative origins of Autographa californica multiple nucleocapsid nuclear polyhedrosis virus DNA replicationJournal of General Virology, 1993
- In SituRetrovirus-Mediated Gene Transfer into Dog LiverHuman Gene Therapy, 1993
- Assessment of Recombinant Adenoviral Vectors for Hepatic Gene TherapyHuman Gene Therapy, 1993
- The Autographa californica Baculovirus Genome: Evidence for Multiple Replication OriginsScience, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976